🔎 Trials Near Me

Domov › Akútna myeloidná leukémia › Missouri › St. Louis

Klinické štúdie Akútna myeloidná leukémia v meste St. Louis, MO

22 štúdií pre Akútna myeloidná leukémia hľadá účastníkov v zariadeniach v meste St. Louis a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.

Oficiálny text štúdie (anglicky)

Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Prebieha náborFáza 2
  • Washington University School of Medicine, St Louis
  • Siteman Cancer Center-South County, St Louis
  • Missouri Baptist Medical Center, St Louis
  • a 3 ďalších
Vek 18 a viac · Všetky pohlavia · Aktualizované 5. 10. 2026 · NCT05564390

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
  • Mercy Infusion Center - Chippewa, St Louis
  • Mercy Hospital South, St Louis
  • Missouri Baptist Medical Center, St Louis
  • a 4 ďalších
Vek 40 až 75 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT05334069

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

Prebieha náborFáza 1
  • Washington University School of Medicine, St Louis
  • Siteman Cancer Center-South County, St Louis
  • Siteman Cancer Center at Christian Hospital, St Louis
  • a 1 ďalších
Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT06484062

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Prebieha náborFáza 2
  • Washington University School of Medicine, St Louis
  • Siteman Cancer Center-South County, St Louis
  • Siteman Cancer Center at Christian Hospital, St Louis
  • a 2 ďalších
Vek 18 až 59 · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT05554393

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

Prebieha náborFáza 3
  • Washington University in St Louis, St Louis
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06852222

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Prebieha náborFáza 2
  • Washington University School of Medicine, St Louis
  • Siteman Cancer Center-South County, St Louis
  • Siteman Cancer Center at Christian Hospital, St Louis
  • a 2 ďalších
Vek 18 až 59 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT05554406

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Prebieha náborFáza 2
  • Washington University School of Medicine, St Louis
  • Siteman Cancer Center-South County, St Louis
  • Siteman Cancer Center at Christian Hospital, St Louis
  • a 3 ďalších
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Prebieha náborFáza 3
  • Washington University School of Medicine, St Louis
  • Mercy Hospital Saint Louis, St Louis
6 Months – 21 Years · Všetky pohlavia · Aktualizované 17. 9. 2026 · NCT04293562

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

Prebieha náborFáza 1/2
  • Washington University in St. Louis School of Medicine, St Louis
30 Days · Všetky pohlavia · Aktualizované 16. 9. 2026 · NCT04065399

A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies

Prebieha náborObservačná štúdia
  • Washington University in St. Louis, St Louis
Vek 0 a viac · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT07154823

Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)

Prebieha náborFáza 3
  • US-St Louis MO-WASHU, St Louis
Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 9. 2026 · NCT07223814

Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML

Prebieha náborFáza 1
  • Washington University in St Louis, St Louis
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 8. 2026 · NCT06533761

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Prebieha náborFáza 1/2
  • Cardinal Glennon Children's Medical Center, St Louis
  • Washington University School of Medicine, St Louis
  • Mercy Hospital Saint Louis, St Louis
Do veku 22 · Všetky pohlavia · Aktualizované 25. 8. 2026 · NCT04726241

Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML

Prebieha náborFáza 1/2
  • Washington University School of Medicine, St Louis
Vek 18 a viac · Všetky pohlavia · Aktualizované 24. 8. 2026 · NCT06158828

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Prebieha náborFáza 3
  • Washington University School of Medicine in St. Louis, St Louis
29 Days – 21 Years · Všetky pohlavia · Aktualizované 24. 8. 2026 · NCT05183035

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Prebieha náborFáza 1
  • Washington University School of Medicine, St Louis
Vek 18 a viac · Všetky pohlavia · Aktualizované 20. 8. 2026 · NCT06001788

Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation

Prebieha náborFáza 2
  • Washington University, St Louis
Vek 18 a viac · Všetky pohlavia · Aktualizované 11. 8. 2026 · NCT06529731

Motixafortide for MRD Sensitization in AML

Prebieha náborFáza 2
  • Washington University School of Medicine, St Louis
Vek 18 a viac · Všetky pohlavia · Aktualizované 24. 7. 2026 · NCT07392970

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Prebieha náborObservačná štúdia
  • Cardinal Glennon Children's Medical Center, St Louis
  • Washington University St. Louis, St Louis
  • Washington University/St. Louis Children's Hospital, St Louis
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 6. 7. 2026 · NCT01351545

A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

Prebieha náborFáza 1
  • Washington University in St. Louis, St Louis
Vek 12 a viac · Všetky pohlavia · Aktualizované 16. 3. 2026 · NCT06994676

Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS

Prebieha náborVítaní zdravých dobrovoľníkov
  • Washington University School of Medicine, St Louis
Vek 18 a viac · Všetky pohlavia · Aktualizované 16. 10. 2025 · NCT04986657

Štúdie Akútna myeloidná leukémia v iných mestách

Iné štúdie v St. Louis

Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.